|
KMID : 0545120170270101855
|
|
Journal of Microbiology and Biotechnology
2017 Volume.27 No. 10 p.1855 ~ p.1866
|
|
|
Specific Expression of Interferon-γ Induced by Synergistic Activation Mediator-Derived Systems Activates Innate Immunity and Inhibits Tumorigenesis
|
|
Liu Shuai
Yu Xiao
Wang Qiankun
Liu Zhepeng
Xiao Qiaoqiao
Hou Panpan
Hu Ying
Hou Wei
Yang Zhanqiu
Guo Deyin
Chen Shuliang
|
|
|
Abstract
|
|
|
|
The synergistic activation mediator (SAM) system can robustly activate endogenous gene expression by a single-guide RNA. This transcriptional modulation has been shown to enhance gene promoter activity and leads to epigenetic changes. Human interferon-γ is a common natural glycoprotein involved in antiviral effects and inhibition of cancer cell growth. Large quantities of high-purity interferon-γ are important for medical research and clinical therapy. To investigate the possibility of employing the SAM system to enhance endogenous human interferon-γ with normal function in innate immunity, we designed 10 single-guide RNAs that target 200 bp upstream of the transcription start sites of the interferon-γ genome, which could significantly activate the interferon-γ promoter reporter. We confirmed that the system can effectively and highly activate interferon-γ expression in several humanized cell lines. Moreover, we found that the interferon-γ induced by the SAM system could inhibit tumorigenesis. Taken together, our results reveal that the SAM system can modulate epigenetic traits of non-immune cells through activating interferon-γ expression and triggering JAK-STAT signaling pathways. Thus, this strategy could offer a novel approach to inhibit tumorigenesis without using exogenous interferon-γ.
|
|
|
KEYWORD
|
|
|
Synergistic activation mediator (SAM), CRISPR-dCas9, humanized interferon-γ, JAK/STAT signaling pathway, tumorigenesis
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|